Abstract
Acute Respiratory Distress Syndrome (ARDS) is a devastating clinical disorder with high mortality rates and no specific pharmacological treatment available yet. It is characterized by excessive inflammation in the alveolar compartment resulting in edema of the airspaces due to loss of integrity in the alveolar epithelial–endothelial barrier leading to the development of hypoxemia and often severe respiratory failure. Changes in the permeability of the alveolar epithelial–endothelial barrier contribute to excessive inflammation, the formation of lung edema and impairment of the alveolar fluid clearance. In recent years, Mesenchymal Stromal Cells (MSCs) have attracted attention as a cell therapy for ARDS. MSCs are known to secrete a variety of biologically active factors (growth factors, cytokines, and extracellular vesicles). These paracrine factors have been shown to be major effectors of the anti-inflammatory and regenerative properties observed in multiple in vitro and in vivo studies. This chapter provides a simple protocol on how to investigate the paracrine effect of MSCs on the alveolar epithelial–endothelial barrier functions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
de Castro LL, Lopes-Pacheco M, Weiss DJ et al (2019) Current understanding of the immunosuppressive properties of mesenchymal stromal cells. J Mol Med Ther Ber 97(5):605–618
Fergie N, Todd N, McClements L et al (2019) Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair. FASEB J 33(4):5585–5598
Morrison TJ, Jackson MV, Cunningham EK et al (2017) Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med 196(10):1275–1286
Jackson MV, Morrison TJ, Doherty DF et al (2016) Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS. Stem Cells 34(8):2210–2223
Silva JD, Lopes-Pacheco M, Paz AHR et al (2018) Mesenchymal stem cells from bone marrow, adipose tissue, and lung tissue differentially mitigate lung and distal organ damage in experimental acute respiratory distress syndrome. Crit Care Med 46(2):e132–e140
Maron-Gutierrez T, Silva JD, Asensi KD et al (2013) Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice. Crit Care Med 41(11):e319–e333
Brown C, McKee C, Bakshi S et al (2019) Mesenchymal stem cells: cell therapy and regeneration potential. J Tissue Eng Regen Med 13(9):1738–1755
Murray LM, Krasnodembskaya AD (2019) Concise review:intercellular communication via organelle transfer in biology and therapeutic applications of stem cells. Stem Cells 37(1):14–25
Weiss DJ, English K, Krasnodembskaya A et al (2019) The necrobiology of mesenchymal stromal cells affects therapeutic efficacy. Front Immunol 10:1228. https://doi.org/10.3389/fimmu.2019.01228
Ware LB, Bastarache JA, Bernard GR (2017) Acute respiratory distress syndrome. In: Vincent J-L et al (eds) Textbook of critical care, 7th edn. Elsevier, Philadelphia, pp 413–424
Lee JW, Fang X, Gupta N et al (2009) Allogeneic human mesenchymal stem cells for the treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A 106(38):16,357–16,362
X1 F, Neyrinck AP, Matthay MA, Lee JW (2010) Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. J Biol Chem 285(34):26211–26222
Islam MN, Das SR, Emin MT et al (2012) Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 18(5):759–765
Miller I, Min M, Yang C et al (2018) Ki67 is a graded rather than a binary marker of proliferation versus quiescence. Cell Rep 24(5):1105–1112.e5
Samary CS, Ramos AB, Maia LA et al (2018) Focal ischemic stroke leads to lung injury and reduces alveolar macrophage phagocytic capability in rats. Crit Care 22(1):249
Abreu SC, Antunes MA, Xisto DG et al (2017) Bone marrow, adipose, and lung tissue-derived murine mesenchymal stromal cells release different mediators and differentially affect airway and lung parenchyma in experimental asthma. Stem Cells Transl Med 6(6):1557–1567
Buachan P, Chularojmontri L, Wattanapitayakul S (2014) Selected activities of Citrus Maxima merr. Fruits on human endothelial cells: enhancing cell migration and delaying cellular aging. Nutrients 6:1618–1634
Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317
Théry C, Witwer KW, Aikawa E et al (2018) Minimal information for studies of extracellular vesicles (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Silva, J.D., Krasnodembskaya, A.D. (2021). Investigation of the MSC Paracrine Effects on Alveolar–Capillary Barrier Integrity in the In Vitro Models of ARDS. In: Stock, P., Christ, B. (eds) In Vitro Models for Stem Cell Therapy. Methods in Molecular Biology, vol 2269. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1225-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1225-5_5
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1224-8
Online ISBN: 978-1-0716-1225-5
eBook Packages: Springer Protocols